JUBLINGREA

Jubilant Ingrevia Financial Results

₹630.00-2.21%
Market cap
₹9,936 crore
P/E
32.2
P/B
3.18
ROE
9.2%
Dividend yield
0.40%

For the year ended Mar 2021, Jubilant Ingrevia reported revenue of ₹684 crore and net profit of ₹54 crore, against ₹4,949 crore and ₹477 crore a year earlier.

Jubilant Ingrevia annual profit and loss

Financial years, newest first. TTM = trailing twelve months.

Jubilant Ingrevia annual profit and loss (₹ crore)
ItemMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue6844,9494,7404,1004,1244,3454,604
Expenses5674,1184,1743,6703,5983,7563,958
Operating profit117832566430526589646
Operating margin %17%17%12%10%13%14%14%
Other income-103113263054
Interest7312052554953
Depreciation22123122136158175186
Profit before tax77709437268344370411
Tax %30%33%30%32%27%25%25%
Net profit54477307183251278309
EPS (₹)3.4129.9319.3111.5815.8817.6219.57
Dividend payout %———————

Source: Company filings (consolidated), in ₹ crore. Data as of 7 October 2026. How this data is compiled.

Jubilant Ingrevia financial results — frequently asked questions

What is Jubilant Ingrevia's annual revenue and net profit?

For the financial year ended Mar 2021, Jubilant Ingrevia's revenue was ₹684 crore and net profit ₹54 crore; net profit fell 88.68% from ₹477 crore in Mar 2022.

How fast has Jubilant Ingrevia grown over three years?

From Mar 2024 to Mar 2021, Jubilant Ingrevia's revenue grew at a compound annual rate of -44.9% and net profit at -33.4%. Past growth does not indicate future results.

What is the EPS of Jubilant Ingrevia?

Annual EPS for Mar 2021 was ₹3.41.

Are these figures consolidated or standalone?

They are consolidated figures as reported by the company, in ₹ crore. Trailing-twelve-month and half-year columns are labelled separately and are not counted as financial years.

Same Data For Peers

Trade Jubilant Ingrevia With ATS

Track JUBLINGREA live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.